Laura-Christin Pierchalla

Malteser-Krankenhaus

Papers

1

Total Citations

18

H-Index

1

About

Laura-Christin Pierchalla is a surgical oncologist whose work is advancing the treatment of testicular germ cell tumours through minimally invasive techniques. Her primary research focuses on robotic retroperitoneal lymph node dissection (R-RPLND), a complex procedure for managing metastatic disease. In her most-cited study, she provided critical data on the indications, feasibility, and outcomes of R-RPLND, addressing a significant gap in the literature where the procedure’s role remains debated. Her findings, which have garnered 18 citations, demonstrate that robotic surgery can be a viable, less invasive option for select patients, potentially reducing recovery times and complications compared to traditional open surgery. Beyond this, Pierchalla’s work contributes to the broader field of urologic oncology, emphasizing the importance of refining surgical approaches to improve patient quality of life. Her research is particularly valuable for clinicians and trainees seeking evidence-based guidance on adopting robotic techniques in challenging oncologic cases. By systematically evaluating this emerging technology, Pierchalla is helping to shape future standards of care for testicular cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Indications, feasibility and outcome of robotic retroperitoneal lymph node dissection for metastatic testicular germ cell tumours
18 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Malteser-Krankenhaus

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago